SEQH CAPITAL RESEARCH - TEAR SHEET
VISTRA (VST) - PRICED FOR ERCOT, BUILT FOR HYPERSCALERS
WHAT THIS REPORT ARGUES
Vistra has fallen roughly 31 percent over the past year as investors focused on weaker ERCOT power prices and a broader de-rating of the AI-power trade. SEQH’s view is that the market is treating VST like a spot-power merchant when its cash flows are increasingly hedged, contracted, and supported by long-duration nuclear offtake.
The central thesis is that Vistra’s signed AWS and Meta nuclear PPAs, PJM capacity scarcity, discounted power-asset replacement value, and acquisition-led earnings growth create a more durable infrastructure-style cash-flow profile than the current share price reflects.
Core thesis
Vistra’s 2027 generation is approximately 94 percent hedged, so a $5/MWh ERCOT price move changes 2027 EBITDA by only around $27 million, or roughly 0.3 percent of the report’s pro forma estimate.
The company has 3,809 MW of nuclear capacity under 20-year hyperscaler PPAs: 1,200 MW with AWS at Comanche Peak and 2,609 MW with Meta across its PJM nuclear fleet, including uprates.
SEQH estimates that these contracts generate approximately $1.98 billion of annual run-rate EBITDA at full delivery, with a present value of roughly $16.3 billion, equal to about 35 percent of Vistra’s market capitalization.
The report’s base-case intrinsic value is $175 per share, or about 27 percent above the September 25 reference price of $138.46. The probability-weighted outcome is $171, with a Monte Carlo median of $156 and a modeled 66 percent probability that value exceeds the prevailing share price.
The contracted nuclear floor
The AWS and Meta agreements change the nature of Vistra’s nuclear fleet from primarily merchant generation into contracted infrastructure serving some of the world’s most creditworthy AI and cloud counterparties.
SEQH assumes a blended contracted price of about $96.60/MWh, against estimated all-in nuclear cash cost of approximately $32/MWh.
The report treats the existing signed contracts as the base case and leaves additional nuclear contracting opportunity out of its core valuation. Management has identified as much as 3.2 GW of further contracting potential across Beaver Valley and Comanche Peak, including uprates.
Under SEQH’s framework, each additional 1 GW contracted near the assumed price range could add roughly $282 million of annual EBITDA and approximately $8 per share of value.
ERCOT risk is hedged
ERCOT power prices near $30/MWh have weighed heavily on sentiment, but Vistra is not fully exposed to spot pricing because of its hedge book and vertically integrated generation-and-retail platform.
The report estimates that a $10/MWh ERCOT shock moves 2027 EBITDA by only about $54 million, or around 0.6 percent of pro forma 2027 EBITDA.
Nuclear output also benefits from the Section 45U production-tax-credit structure in the low-price environment bears fear. At around $30/MWh ERCOT pricing, the report estimates Comanche Peak’s effective merchant realization could rise to roughly $44/MWh after the credit.
The result is that lower ERCOT pricing may actually widen the economic advantage of a long-term hyperscaler nuclear PPA relative to merchant alternatives.
PJM scarcity and replacement value
PJM’s 2028/29 capacity auction cleared at the $325/MW-day collar while the market remained about 6,831 MW short of its reliability requirement. PJM’s own uncapped simulation indicated a clearing price of about $554.72/MW-day.
SEQH estimates that the collar suppresses roughly $639 million per year of potential capacity value on Vistra’s PJM exposure, before including Cogentrix assets.
Vistra is also valued below estimated replacement cost. The report calculates pro forma enterprise value near $1,483/kW, versus an estimated $2,200/kW to build new combined-cycle gas capacity.
The pending Cogentrix acquisition reinforces that theme: it adds approximately 5.5 GW of gas generation at roughly $855/kW and around 6.75x EBITDA, materially below Vistra’s own valuation multiple.
Uranium is a tailwind
The report argues that uranium-price exposure is relatively small for Vistra compared with the scarcity value of its operating nuclear fleet.
A $10/lb increase in U3O8 is estimated to cost Vistra only about $28 million annually, or roughly $0.54/MWhof nuclear generation.
Even a $100/lb uranium shock is modeled at about 3 percent of 2028 EBITDA, while nuclear scarcity can create much larger value through PPAs, capacity pricing, reactor-life extensions, and uprates.
SEQH therefore sees operators such as Vistra and fuel-cycle companies as complementary beneficiaries of the same nuclear-scarcity cycle.
Financial model and catalysts
The report projects pro forma EBITDA rising from about $7.2 billion in 2026 to $8.47 billion in 2027 and $9.04 billion in 2028, helped by Cogentrix, Meta nuclear delivery, AWS ramping, and eventual nuclear uprates.
Key upcoming catalysts include Cogentrix closing in late 2026, first Perry delivery to Meta in December 2026, AWS Comanche Peak delivery beginning in Q4 2027, Davis-Besse delivery to Meta in late 2027, future reactor uprates, and additional nuclear contracting.
The next earnings report is scheduled for November 5, 2026, with investors watching for confirmation that 2026 performance remains at or above the midpoint of guidance and for updated Cogentrix outlook.
Main risks
The most important risks are structurally weak ERCOT pricing, lower-than-assumed AWS or Meta PPA economics, hyperscaler capex delays, PJM capacity-market intervention, nuclear outages, and potential dilution or leverage associated with acquisitions.
The report also flags Moss Landing remediation costs, GAAP volatility from unrealized hedge marks, and the possibility that the PJM collar remains in place longer than expected.
SEQH’s bear case reaches $90 per share, while the bull case reaches $244, depending primarily on organic EBITDA, PPA pricing, ERCOT conditions, and valuation multiple normalization.
Bottom line
The clean takeaway is that Vistra is no longer just an ERCOT merchant-power trade. It is increasingly a hedged, contracted nuclear-and-gas infrastructure platform with long-duration hyperscaler contracts embedded in the cash-flow base.
The report’s argument is that the market is discounting a permanently shrinking business, while the underlying model points to growth from signed PPAs, PJM scarcity, acquisition accretion, and a still-underappreciated nuclear contracting opportunity.
What readers get in the full PDF BELOW
Upgrade to access the complete Vistra deep dive, including:
The full AWS and Meta nuclear PPA valuation model, including pricing sensitivities and run-rate EBITDA uplift.
Detailed ERCOT hedge exposure and nuclear tax-credit analysis.
The full PJM scarcity and capacity-price framework, including collar-related shadow value.
Pro forma Cogentrix acquisition economics, replacement-cost analysis, and long-term EBITDA and free-cash-flow forecasts.
A complete DCF, reverse DCF, scenario analysis, and 100,000-path Monte Carlo model.
The full catalyst calendar, risk register, uranium sensitivity table, and the assumptions behind SEQH’s $175 base-case value.
